AIM ImmunoTech (AIM) Asset Utilization Ratio (2011 - 2026)
AIM ImmunoTech's Asset Utilization Ratio was 0.01 in Q2 2026, down 61.8% from 0.02 a year earlier and down 31.9% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
From Q3 2011 onward, AIM ImmunoTech has reported Asset Utilization Ratio for 55 quarters.
- Asset Utilization Ratio has now increased for four consecutive years.
- In earlier years, Asset Utilization Ratio was 0.01 in FY2024 (+80.0%), 0.01 in FY2023 (+135.0%), 0.00 in FY2022 (+30.1%) and 0.00 in FY2021 (-42.2%).
- The Q2 2026 figure marks the lowest quarterly Asset Utilization Ratio since Q4 2023.
- Compared with a year earlier, Asset Utilization Ratio was higher in six of the last eight quarters, with growth averaging 42.3%.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q1 2024 (growth of 171.1%); the worst was Q2 2026 (a decline of 61.8%).
- Per Business Quant data, AIM's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.01 (Q1 2026), 0.02 (Q4 2025) and 0.02 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
API Access
AIM ImmunoTech Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();